お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は糖尿病の幹細胞治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは糖尿病の幹細胞治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の糖尿病の幹細胞治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは糖尿病の幹細胞治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に糖尿病の幹細胞治療市場を分類しています。本研究に含まれる主な企業は：Seraxi、Vertex Pharmaceuticals、CRISPR Therapeutics、iTolerance、Sernova、Eli Lilly、CellTrans

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Preclinical
    Clinical Phase

用途別の市場セグメント：
    Type 1 Diabetes
    Type 2 Diabetes

本レポートの詳細内容
世界の糖尿病の幹細胞治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、糖尿病の幹細胞治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の糖尿病の幹細胞治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の糖尿病の幹細胞治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、糖尿病の幹細胞治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

糖尿病の幹細胞治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：糖尿病の幹細胞治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：糖尿病の幹細胞治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章糖尿病の幹細胞治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：糖尿病の幹細胞治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：糖尿病の幹細胞治療の主要企業の概要を提供し、製品の説明と仕様、糖尿病の幹細胞治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

The global Diabetes Stem Cell Therapy market is projected to grow from US$ 127 million in 2024 to US$ 2073 million by 2030, at a Compound Annual Growth Rate (CAGR) of 59.3% during the forecast period.
North America key players of Diabetes Stem Cell Therapy include CellTrans, Seraxi, Vertex Pharmaceuticals, CRISPR Therapeutics, iTolerance, etc. The top five players hold a share about 100%.
Report Includes
This report presents an overview of global market for Diabetes Stem Cell Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Diabetes Stem Cell Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Diabetes Stem Cell Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Diabetes Stem Cell Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Diabetes Stem Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Diabetes Stem Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Seraxi, Vertex Pharmaceuticals, CRISPR Therapeutics, iTolerance, Sernova, Eli Lilly, CellTrans, etc.

Market Segmentation
By Company
    Seraxi
    Vertex Pharmaceuticals
    CRISPR Therapeutics
    iTolerance
    Sernova
    Eli Lilly
    CellTrans

Segment by Type
    Preclinical
    Clinical Phase

Segment by Application
    Type 1 Diabetes
    Type 2 Diabetes

By Region
    North America
        United States
        Canada
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Latin America
        Mexico
        Brazil
        Rest of South America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Diabetes Stem Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Stem Cell Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetes Stem Cell Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
 Table 1. Global Diabetes Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Preclinical
 Table 3. Key Players of Clinical Phase
 Table 4. Global Diabetes Stem Cell Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Diabetes Stem Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Diabetes Stem Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Diabetes Stem Cell Therapy Market Share by Region (2019-2024)
 Table 8. Global Diabetes Stem Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Diabetes Stem Cell Therapy Market Share by Region (2025-2030)
 Table 10. Diabetes Stem Cell Therapy Market Trends
 Table 11. Diabetes Stem Cell Therapy Market Drivers
 Table 12. Diabetes Stem Cell Therapy Market Challenges
 Table 13. Diabetes Stem Cell Therapy Market Restraints
 Table 14. Global Diabetes Stem Cell Therapy Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Diabetes Stem Cell Therapy Market Share by Players (2019-2024)
 Table 16. Global Top Diabetes Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Stem Cell Therapy as of 2023)
 Table 17. Global Diabetes Stem Cell Therapy Industry Ranking 2022 VS 2023
 Table 18. Global 5 Largest Players Market Share by Diabetes Stem Cell Therapy Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Diabetes Stem Cell Therapy, Headquarters and Area Served
 Table 20. Global Key Players of Diabetes Stem Cell Therapy, Product and Application
 Table 21. Global Key Players of Diabetes Stem Cell Therapy, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Diabetes Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Diabetes Stem Cell Therapy Revenue Market Share by Type (2019-2024)
 Table 25. Global Diabetes Stem Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Diabetes Stem Cell Therapy Revenue Market Share by Type (2025-2030)
 Table 27. Global Diabetes Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Diabetes Stem Cell Therapy Revenue Market Share by Application (2019-2024)
 Table 29. Global Diabetes Stem Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Diabetes Stem Cell Therapy Revenue Market Share by Application (2025-2030)
 Table 31. North America Diabetes Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
 Table 32. North America Diabetes Stem Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
 Table 33. North America Diabetes Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
 Table 34. North America Diabetes Stem Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
 Table 35. North America Diabetes Stem Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. North America Diabetes Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
 Table 37. North America Diabetes Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Europe Diabetes Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
 Table 39. Europe Diabetes Stem Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
 Table 40. Europe Diabetes Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
 Table 41. Europe Diabetes Stem Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
 Table 42. Europe Diabetes Stem Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Europe Diabetes Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Europe Diabetes Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
 Table 45. China Diabetes Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
 Table 46. China Diabetes Stem Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
 Table 47. China Diabetes Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
 Table 48. China Diabetes Stem Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
 Table 49. Asia Diabetes Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
 Table 50. Asia Diabetes Stem Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
 Table 51. Asia Diabetes Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
 Table 52. Asia Diabetes Stem Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
 Table 53. Asia Diabetes Stem Cell Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 54. Asia Diabetes Stem Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
 Table 55. Asia Diabetes Stem Cell Therapy Market Size by Region (2025-2030) & (US$ Million)
 Table 56. Middle East, Africa, and Latin America Diabetes Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
 Table 57. Middle East, Africa, and Latin America Diabetes Stem Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
 Table 58. Middle East, Africa, and Latin America Diabetes Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
 Table 59. Middle East, Africa, and Latin America Diabetes Stem Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
 Table 60. Middle East, Africa, and Latin America Diabetes Stem Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 61. Middle East, Africa, and Latin America Diabetes Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
 Table 62. Middle East, Africa, and Latin America Diabetes Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
 Table 63. Seraxi Company Details
 Table 64. Seraxi Business Overview
 Table 65. Seraxi Diabetes Stem Cell Therapy Product
 Table 66. Seraxi Revenue in Diabetes Stem Cell Therapy Business (2019-2024) & (US$ Million)
 Table 67. Seraxi Recent Development
 Table 68. Vertex Pharmaceuticals Company Details
 Table 69. Vertex Pharmaceuticals Business Overview
 Table 70. Vertex Pharmaceuticals Diabetes Stem Cell Therapy Product
 Table 71. Vertex Pharmaceuticals Revenue in Diabetes Stem Cell Therapy Business (2019-2024) & (US$ Million)
 Table 72. Vertex Pharmaceuticals Recent Development
 Table 73. CRISPR Therapeutics Company Details
 Table 74. CRISPR Therapeutics Business Overview
 Table 75. CRISPR Therapeutics Diabetes Stem Cell Therapy Product
 Table 76. CRISPR Therapeutics Revenue in Diabetes Stem Cell Therapy Business (2019-2024) & (US$ Million)
 Table 77. CRISPR Therapeutics Recent Development
 Table 78. iTolerance Company Details
 Table 79. iTolerance Business Overview
 Table 80. iTolerance Diabetes Stem Cell Therapy Product
 Table 81. iTolerance Revenue in Diabetes Stem Cell Therapy Business (2019-2024) & (US$ Million)
 Table 82. iTolerance Recent Development
 Table 83. Sernova Company Details
 Table 84. Sernova Business Overview
 Table 85. Sernova Diabetes Stem Cell Therapy Product
 Table 86. Sernova Revenue in Diabetes Stem Cell Therapy Business (2019-2024) & (US$ Million)
 Table 87. Sernova Recent Development
 Table 88. Eli Lilly Company Details
 Table 89. Eli Lilly Business Overview
 Table 90. Eli Lilly Diabetes Stem Cell Therapy Product
 Table 91. Eli Lilly Revenue in Diabetes Stem Cell Therapy Business (2019-2024) & (US$ Million)
 Table 92. Eli Lilly Recent Development
 Table 93. CellTrans Company Details
 Table 94. CellTrans Business Overview
 Table 95. CellTrans Diabetes Stem Cell Therapy Product
 Table 96. CellTrans Revenue in Diabetes Stem Cell Therapy Business (2019-2024) & (US$ Million)
 Table 97. CellTrans Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Diabetes Stem Cell Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 2. Global Diabetes Stem Cell Therapy Market Share by Type: 2023 VS 2030
 Figure 3. Preclinical Features
 Figure 4. Clinical Phase Features
 Figure 5. Global Diabetes Stem Cell Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 6. Global Diabetes Stem Cell Therapy Market Share by Application: 2023 VS 2030
 Figure 7. Type 1 Diabetes Case Studies
 Figure 8. Type 2 Diabetes Case Studies
 Figure 9. Diabetes Stem Cell Therapy Report Years Considered
 Figure 10. Global Diabetes Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 11. Global Diabetes Stem Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Diabetes Stem Cell Therapy Market Share by Region: 2023 VS 2030
 Figure 13. Global Diabetes Stem Cell Therapy Market Share by Players in 2023
 Figure 14. Global Top Diabetes Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Stem Cell Therapy as of 2023)
 Figure 15. The Top 10 and 5 Players Market Share by Diabetes Stem Cell Therapy Revenue in 2023
 Figure 16. North America Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 17. North America Diabetes Stem Cell Therapy Market Share by Type (2019-2030)
 Figure 18. North America Diabetes Stem Cell Therapy Market Share by Application (2019-2030)
 Figure 19. North America Diabetes Stem Cell Therapy Market Share by Country (2019-2030)
 Figure 20. United States Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Diabetes Stem Cell Therapy Market Share by Type (2019-2030)
 Figure 24. Europe Diabetes Stem Cell Therapy Market Share by Application (2019-2030)
 Figure 25. Europe Diabetes Stem Cell Therapy Market Share by Country (2019-2030)
 Figure 26. Germany Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. China Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. China Diabetes Stem Cell Therapy Market Share by Type (2019-2030)
 Figure 34. China Diabetes Stem Cell Therapy Market Share by Application (2019-2030)
 Figure 35. Asia Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Asia Diabetes Stem Cell Therapy Market Share by Type (2019-2030)
 Figure 37. Asia Diabetes Stem Cell Therapy Market Share by Application (2019-2030)
 Figure 38. Asia Diabetes Stem Cell Therapy Market Share by Region (2019-2030)
 Figure 39. Japan Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. South Korea Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. India Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Australia Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East, Africa, and Latin America Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Middle East, Africa, and Latin America Diabetes Stem Cell Therapy Market Share by Type (2019-2030)
 Figure 47. Middle East, Africa, and Latin America Diabetes Stem Cell Therapy Market Share by Application (2019-2030)
 Figure 48. Middle East, Africa, and Latin America Diabetes Stem Cell Therapy Market Share by Country (2019-2030)
 Figure 49. Brazil Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 50. Mexico Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 51. Turkey Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 53. Israel Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 54. GCC Countries Diabetes Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 55. Seraxi Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2019-2024)
 Figure 56. Vertex Pharmaceuticals Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2019-2024)
 Figure 57. CRISPR Therapeutics Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2019-2024)
 Figure 58. iTolerance Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2019-2024)
 Figure 59. Sernova Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2019-2024)
 Figure 60. Eli Lilly Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2019-2024)
 Figure 61. CellTrans Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2019-2024)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed